SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gian Life Care Ltd (542918)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542918 NSE: Hospital & Healthcare Services | Small Cap | Gian Life Care Share Price

₹4.93 -0.08 (-1.60%)

As on 06-Jul'26 16:59

Gian Life Care Ltd (542918)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542918 NSE: Hospital & Healthcare Services | Small Cap | Gian Life Care Share Price

₹4.93 -0.08 (-1.60%)

As on 06-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹5 Cr.
Current Price
₹4.9
52-Week Low / High
₹5 / 17
TTM EPS
₹-0.7
TTM Sales
₹3.8 Cr.
Book Value per Share
₹18.8
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
93.9
Price to Book (P/B)
0.26
Lower than its 5-year historical median
Price to Sales (P/S)
1.35
Lower than its 5-year historical median
EV/EBITDA
27.09
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
0.79%
Underperforms industry median
Return on Capital Employed (ROCE)
3.00%
Underperforms industry median
Return on Assets (ROA)
0.46%
Operating Profit Margin
14.4%
Net Profit Margin
2.34%
Gross Profit Margin
11.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-49.47%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-84.54%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-96.28%
Asset Quality
Promoter Holding
30.17%
Pledged shares (%) of Promoter's holding (%)
65.08%
Reserves
₹9 Cr.
Equity
₹10.3 Cr.
Face Value
₹10
All Time Low / High
₹4.67 / 65.91

Gian Life Care stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Gian Life Care Ltd a good quality company?
Gian Life Care Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Gian Life Care Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Gian Life Care Ltd vs industry peers?
Gian Life Care Ltd revenue CAGR is -2.82%, compared to the industry median CAGR of 1.38%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Gian Life Care Ltd?
Promoters hold 30.17% of the Gian Life Care Ltd, with 65.08% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Gian Life Care Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -10.57% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gian Life Care Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 12.3%42.5%35.9%53.2%12.4%29.2%3%-
Value Creation
Index
-0.12.01.62.8-0.11.1-0.8-

Growth Parameters

Sales 0.67.710.515.911.913.16.64
Sales YoY Gr.-1,266.1%36.7%52.3%-25.2%10.1%-49.5%-
Adj EPS 0.21.124.21.24.20.2-0.7
YoY Gr.-373.9%78.9%116.9%-71.2%240.2%-96.4%-
BVPS (₹) 0.37.49.313.614.81919.118.8
Adj Net
Profit
0.11.124.41.34.30.2-1
Cash Flow from Ops. 31.52.95.82.30.80.3-
Debt/CF from Ops. 0.50.70.40.425.520-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-2.8%-25.3%-49.5%
Adj EPS NA-32.7%-67.2%-96.4%
BVPSNA20.9%12.1%0.7%
Share Price - -23.5% -40% -67.7%

Key Financial Parameters

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
90.929.123.336.98.624.60.8-3.9
Op. Profit
Mgn %
3530.333.343.517.147.314.410.7
Net Profit
Mgn %
1814.719.327.510.532.72.3-20.4
Debt to
Equity
12.30.10.10.10.30.20.3-
Working Cap
Days
02913212814965451,259842
Cash Conv.
Cycle
0-13-2-47-38-177-125332

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.567.6510.4615.9311.9213.126.63
Operating Expenses + 0.365.336.9899.886.915.67
Manufacturing Costs0.020.230.260.400.470.320.32
Material Costs0.071.593.572.822.761.761.20
Employee Cost 0.111.020.941.311.580.910.59
Other Costs 0.172.492.204.475.073.923.56
Operating Profit 0.202.323.486.932.046.210.96
Operating Profit Margin (%) 35.0%30.3%33.3%43.5%17.1%47.3%14.4%
Other Income + 00.100.290.510.690.640.25
Exceptional Items 0000000
Interest 0.040.610.731.250.450.470.43
Depreciation 0.020.260.290.330.500.460.47
Profit Before Tax 0.141.562.755.851.795.910.30
Tax 0.040.430.741.480.531.620.14
Profit After Tax 0.101.132.024.371.264.300.16
PAT Margin (%) 18.0%14.7%19.3%27.5%10.5%32.7%2.3%
Adjusted EPS (₹)0.21.12.04.21.24.20.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Valuation of Gian Life Care - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 0.117.649.6614.0315.3119.6219.76
Share Capital 0.014.704.7010.3410.3410.3410.34
Reserves 0.102.944.963.694.979.279.42
Debt +0.980.790.671.874.343.694.64
Long Term Debt0.980.750.621.871.651.802.57
Short Term Debt00.040.0502.691.892.07
Minority Interest0000000
Trade Payables1.011.111.631.552.873.073.55
Others Liabilities 5.722.833.525.615.875.697.61
Total Liabilities 7.8212.3715.4823.0628.4032.0735.55

Fixed Assets

Net Fixed Assets +2.912.842.993.504.624.474.01
Gross Block2.933.123.554.3866.316.32
Accumulated Depreciation0.020.280.560.891.391.852.32
CWIP 0000.120.140.140.14
Investments 0000.110.110.110.11
Inventories0.840.861.021.490.880.880.62
Trade Receivables1.321.572.051.783.254.816.09
Cash Equivalents 1.101.132.514.745.755.976.95
Others Assets 1.645.976.9011.3213.6515.6917.65
Total Assets 7.8212.3715.4823.0628.4032.0735.55

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 2.991.512.875.792.320.750.25
PBT 0.141.562.755.851.795.910.30
Adjustment 0.040.600.421.930.260.280.63
Changes in Working Capital 2.81-0.42-0.01-1.320.3-5.42-0.65
Tax Paid 0-0.23-0.30-0.67-0.02-0.02-0.03
Cash Flow From Investing Activity + -2.92-3.96-1.10-4.23-0.940.330.23
Capex -2.93-0.19-0.43-0.96-1.63-0.31-0.01
Net Investments 00.070-0.29000
Others 0-3.85-0.66-2.990.690.640.25
Cash Flow From Financing Activity + 0.962.55-0.390.67-0.37-0.860.49
Net Proceeds from Shares 0.013.1100000
Net Proceeds from Borrowing 0000-0.22-0.250.76
Interest Paid -0.03-0.30-0.30-0.35-0.43-0.45-0.41
Dividend Paid 0000000
Others 0.98-0.26-0.091.020.28-0.160.13
Net Cash Flow 1.030.101.382.231.010.220.97

Financial Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)90.9429.0823.3336.948.5724.590.79
ROCE (%)12.2642.4735.9153.1912.4429.243
Asset Turnover Ratio0.070.760.750.830.460.430.2
PAT to CFO Conversion(x)29.91.341.421.321.840.171.56
Working Capital Days
Receivable Days865.1069.1063.3043.9077112.20300
Inventory Days548.7040.5032.8028.8036.3024.5041.40
Payable Days5,575.40243.60139.90205.802926151,003.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.0026.530.0062.2761.1761.1761.1765.08
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gian Life Care Ltd FAQs

The current trading price of Gian Life Care on 06-Jul-2026 16:59 is ₹4.93.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Jul-2026 the market cap of Gian Life Care stood at ₹5.10 Cr

The latest P/E ratio of Gian Life Care as of 05-Jul-2026 is 0.00.

The latest P/B ratio of Gian Life Care as of 05-Jul-2026 is 0.26.

The 52-week high of Gian Life Care is ₹17.49 and the 52-week low is ₹4.67.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gian Life Care is ₹3.76 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gian Life Care Ltd is a good quality company.

The key valuation ratios of Gian Life Care Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gian Life Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Gian Life Care Ltd

Gian Life Care was incorporated on November 06, 2018, under the provisions of the Companies Act, 2013 by Registrar of Companies, Kanpur. On March 01, 2019 the company took over the entire running business of Gian Pathology and X-Rays, a proprietorship concern of the promoter Arun Kumar Gupta with a view to provide diagnostic and related healthcare tests and services.

Business area of the Company:

The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers over 1,344 tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services. Gian Life is NABL accredited and ISO 9001:2015 certified company.

Key Events and Milestones:

  • 2018: Incorporation of the Company in the name of ‘Gian Life Care Limited’
  • 2019: Acquired the running business along with substantial assets and liabilities of Gian Pathology and X rays, proprietorship concern of the Promoter.

 

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: